Menu
Back to Journals » Journal of Inflammation Research » Volume 17
Original Research
FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 744 | Dovepress* | 744+ | 9 | 753 | |
| Totals | 744 | 9 | 753 | ||
| *Since 19 June 2024 | |||||
View citations on PubMed Central and Google Scholar